Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Surgical Oncology ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States.Cancer Res. 2014; 74: 2913-2921
- Cancer statistics, 2014.CA Cancer J Clin. 2014; 64: 9-29
- Distant metastasis occurs late during the genetic evolution of pancreatic cancer.Nature. 2010; 467: 1114-1117
- Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions.Am J Surg Pathol. 2001; 25: 579-586
- Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways.Proc Natl Acad Sci U S A. 2011; 108: 21188-21193
- Dpc-4 protein is expressed in virtually all human intraductal papillary mucinous neoplasms of the pancreas: comparison with conventional ductal adenocarcinomas.Am J Pathol. 2000; 157: 755-761
- Dpc4 protein in mucinous cystic neoplasms of the pancreas: frequent loss of expression in invasive carcinomas suggests a role in genetic progression.Am J Surg Pathol. 2000; 24: 1544-1548
- Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development.Sci Transl Med. 2011; 3: 92ra66
- Clinical relevance of KRAS in human cancers.J Biomed Biotechnol. 2010; 2010: 150960
- Core signaling pathways in human pancreatic cancers revealed by global genomic analyses.Science. 2008; 321: 1801-1806
- Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets.Nat Commun. 2015; 6: 6744
- The patterns and dynamics of genomic instability in metastatic pancreatic cancer.Nature. 2010; 467: 1109-1113
- Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma.Nat Genet. 1994; 8: 27-32
- Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas.Cancer Res. 1997; 57: 3126-3130
- INK4a/ARF: a multifunctional tumor suppressor locus.Mutat Res. 2005; 576: 22-38
- Pancreatic adenocarcinomas frequently show p53 gene mutations.Am J Pathol. 1993; 142: 1534-1543
- Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray.Mod Pathol. 2003; 16: 902-912
- Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer.Nat Rev Cancer. 2003; 3: 807-821
- Clinical significance of the genetic landscape of pancreatic cancer and implications for identification of potential long-term survivors.Clin Cancer Res. 2012; 18: 6339-6347
- DPC4/Smad4 expression and outcome in pancreatic ductal adenocarcinoma.J Clin Oncol. 2002; 20: 4531-4542
- Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer.Genes Dev. 2006; 20: 3130-3146
- DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer.J Clin Oncol. 2009; 27: 1806-1813
- Familial pancreatic cancer.Arch Pathol Lab Med. 2009; 133: 365-374
- Family history is a significant risk factor for pancreatic cancer: results from a systematic review and meta-analysis.Fam Cancer. 2009; 8: 109-117
- Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers.Am J Pathol. 1999; 154: 1835-1840
- Mutations in the gene encoding the serine protease inhibitor, kazal type 1 are associated with chronic pancreatitis.Nat Genet. 2000; 25: 213-216
- Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group.J Natl Cancer Inst. 1997; 89: 442-446
- Cigarette smoking as a risk factor for pancreatic cancer in patients with hereditary pancreatitis.JAMA. 2001; 286: 169-170
- Heterogeneity of risk for melanoma and pancreatic and digestive malignancies: a melanoma case-control study.Cancer. 2004; 101: 2809-2816
- Fanconi anemia gene mutations in young-onset pancreatic cancer.Cancer Res. 2003; 63: 2585-2588
- Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas.Cancer Res. 1996; 56: 5360-5364
- BRCA1 and pancreatic cancer: pedigree findings and their causal relationships.Cancer Genet Cytogenet. 2005; 158: 119-125
- Update on familial pancreatic cancer.Adv Surg. 2010; 44: 293-311
- Risk of pancreatic cancer in families with Lynch syndrome.JAMA. 2009; 302: 1790-1795
- ATM mutations in patients with hereditary pancreatic cancer.Cancer Discov. 2012; 2: 41-46
- Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients.Nat Commun. 2015; 6: 7686
- Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes.Nature. 2012; 491: 399-405
- Novel roles for Slits and netrins: axon guidance cues as anticancer targets?.Nat Rev Cancer. 2011; 11: 188-197
- In vitro and in vivo characterization of a novel semaphorin 3A inhibitor, SM-216289 or xanthofulvin.J Biol Chem. 2003; 278: 42985-42991
- Whole genomes redefine the mutational landscape of pancreatic cancer.Nature. 2015; 518: 495-501
- Inactivating mutations of RNF43 confer wnt dependency in pancreatic ductal adenocarcinoma.Proc Natl Acad Sci U S A. 2013; 110: 12649-12654
- Detection of circulating tumor DNA in early- and late-stage human malignancies.Sci Transl Med. 2014; 6: 224ra24
- An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage.Nat Med. 2014; 20: 548-554
- Single-cell RNA sequencing identifies extracellular matrix gene expression by pancreatic circulating tumor cells.Cell Rep. 2014; 8: 1905-1918
- Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA.Nature. 2013; 497: 108-112
- Pharmacogenomic modeling of circulating tumor and invasive cells for prediction of chemotherapy response and resistance in pancreatic cancer.Clin Cancer Res. 2014; 20: 5281-5289
- Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer.Nature. 2012; 486: 532-536
- Clonal evolution and therapeutic resistance in solid tumors.Front Pharmacol. 2013; 4: 2
- Computational modeling of pancreatic cancer reveals kinetics of metastasis suggesting optimum treatment strategies.Cell. 2012; 148: 362-375
- Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2.Mol Cell. 2006; 22: 719-729
- Personalizing cancer treatment in the age of global genomic analyses: PALB2 gene mutations and the response to DNA damaging agents in pancreatic cancer.Mol Cancer Ther. 2011; 10: 3-8
- In vivo therapeutic responses contingent on Fanconi anemia/BRCA2 status of the tumor.Clin Cancer Res. 2005; 11: 7508-7515
- Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy.Nature. 2005; 434: 917-921
- BRCA2-deficient CAPAN-1 cells are extremely sensitive to the inhibition of Poly (ADP-Ribose) polymerase: an issue of potency.Cancer Biol Ther. 2005; 4: 934-936
- Applying synthetic lethality for the selective targeting of cancer.N Engl J Med. 2014; 371: 1725-1735
- Essential gene profiles in breast, pancreatic, and ovarian cancer cells.Cancer Discov. 2012; 2: 172-189
- Targeting oncogenic ras signaling in hematologic malignancies.Blood. 2012; 120: 3397-3406
- A central role for RAF–>MEK–>ERK signaling in the genesis of pancreatic ductal adenocarcinoma.Cancer Discov. 2012; 2: 685-693
- The clinical effect of the dual-targeting strategy involving PI3K/AKT/mTOR and RAS/MEK/ERK pathways in patients with advanced cancer.Clin Cancer Res. 2012; 18: 2316-2325
Article info
Identification
Copyright
© 2016 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
